Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,763
archived clinical trials in
Colitis

IBP-9414 for the Prevention of Necrotizing Enterocolitis
A Randomized, Double Blind, Parallel-group, Dose Escalation Placebo-controlled Multicenter Study to Investigate the Safety and Tolerability of IBP-9414 Administered in Preterm Infants.
Status: Enrolling
Updated:  12/28/2017
University of Florida Health
mi
from
Gainesville, FL
IBP-9414 for the Prevention of Necrotizing Enterocolitis
A Randomized, Double Blind, Parallel-group, Dose Escalation Placebo-controlled Multicenter Study to Investigate the Safety and Tolerability of IBP-9414 Administered in Preterm Infants.
Status: Enrolling
Updated: 12/28/2017
University of Florida Health
mi
from
Gainesville, FL
Click here to add this to my saved trials
IBP-9414 for the Prevention of Necrotizing Enterocolitis
A Randomized, Double Blind, Parallel-group, Dose Escalation Placebo-controlled Multicenter Study to Investigate the Safety and Tolerability of IBP-9414 Administered in Preterm Infants.
Status: Enrolling
Updated:  12/28/2017
Wesley Medical Center
mi
from
Wichita, KA
IBP-9414 for the Prevention of Necrotizing Enterocolitis
A Randomized, Double Blind, Parallel-group, Dose Escalation Placebo-controlled Multicenter Study to Investigate the Safety and Tolerability of IBP-9414 Administered in Preterm Infants.
Status: Enrolling
Updated: 12/28/2017
Wesley Medical Center
mi
from
Wichita, KA
Click here to add this to my saved trials
IBP-9414 for the Prevention of Necrotizing Enterocolitis
A Randomized, Double Blind, Parallel-group, Dose Escalation Placebo-controlled Multicenter Study to Investigate the Safety and Tolerability of IBP-9414 Administered in Preterm Infants.
Status: Enrolling
Updated:  12/28/2017
Jackson Madison County General Hospital
mi
from
Jackson, TN
IBP-9414 for the Prevention of Necrotizing Enterocolitis
A Randomized, Double Blind, Parallel-group, Dose Escalation Placebo-controlled Multicenter Study to Investigate the Safety and Tolerability of IBP-9414 Administered in Preterm Infants.
Status: Enrolling
Updated: 12/28/2017
Jackson Madison County General Hospital
mi
from
Jackson, TN
Click here to add this to my saved trials
IBP-9414 for the Prevention of Necrotizing Enterocolitis
A Randomized, Double Blind, Parallel-group, Dose Escalation Placebo-controlled Multicenter Study to Investigate the Safety and Tolerability of IBP-9414 Administered in Preterm Infants.
Status: Enrolling
Updated:  12/28/2017
Jackson Memorial Hospital
mi
from
Miami, FL
IBP-9414 for the Prevention of Necrotizing Enterocolitis
A Randomized, Double Blind, Parallel-group, Dose Escalation Placebo-controlled Multicenter Study to Investigate the Safety and Tolerability of IBP-9414 Administered in Preterm Infants.
Status: Enrolling
Updated: 12/28/2017
Jackson Memorial Hospital
mi
from
Miami, FL
Click here to add this to my saved trials
IBP-9414 for the Prevention of Necrotizing Enterocolitis
A Randomized, Double Blind, Parallel-group, Dose Escalation Placebo-controlled Multicenter Study to Investigate the Safety and Tolerability of IBP-9414 Administered in Preterm Infants.
Status: Enrolling
Updated:  12/28/2017
Wolfson Children´s Hospital
mi
from
Jacksonville, FL
IBP-9414 for the Prevention of Necrotizing Enterocolitis
A Randomized, Double Blind, Parallel-group, Dose Escalation Placebo-controlled Multicenter Study to Investigate the Safety and Tolerability of IBP-9414 Administered in Preterm Infants.
Status: Enrolling
Updated: 12/28/2017
Wolfson Children´s Hospital
mi
from
Jacksonville, FL
Click here to add this to my saved trials
IBP-9414 for the Prevention of Necrotizing Enterocolitis
A Randomized, Double Blind, Parallel-group, Dose Escalation Placebo-controlled Multicenter Study to Investigate the Safety and Tolerability of IBP-9414 Administered in Preterm Infants.
Status: Enrolling
Updated:  12/28/2017
UF Health Jacksonville
mi
from
Jacksonville, FL
IBP-9414 for the Prevention of Necrotizing Enterocolitis
A Randomized, Double Blind, Parallel-group, Dose Escalation Placebo-controlled Multicenter Study to Investigate the Safety and Tolerability of IBP-9414 Administered in Preterm Infants.
Status: Enrolling
Updated: 12/28/2017
UF Health Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
IBP-9414 for the Prevention of Necrotizing Enterocolitis
A Randomized, Double Blind, Parallel-group, Dose Escalation Placebo-controlled Multicenter Study to Investigate the Safety and Tolerability of IBP-9414 Administered in Preterm Infants.
Status: Enrolling
Updated:  12/28/2017
Timpanogos Regional Hospital
mi
from
Orem, UT
IBP-9414 for the Prevention of Necrotizing Enterocolitis
A Randomized, Double Blind, Parallel-group, Dose Escalation Placebo-controlled Multicenter Study to Investigate the Safety and Tolerability of IBP-9414 Administered in Preterm Infants.
Status: Enrolling
Updated: 12/28/2017
Timpanogos Regional Hospital
mi
from
Orem, UT
Click here to add this to my saved trials
IBP-9414 for the Prevention of Necrotizing Enterocolitis
A Randomized, Double Blind, Parallel-group, Dose Escalation Placebo-controlled Multicenter Study to Investigate the Safety and Tolerability of IBP-9414 Administered in Preterm Infants.
Status: Enrolling
Updated:  12/28/2017
UCLA Medical Center
mi
from
Los Angeles, CA
IBP-9414 for the Prevention of Necrotizing Enterocolitis
A Randomized, Double Blind, Parallel-group, Dose Escalation Placebo-controlled Multicenter Study to Investigate the Safety and Tolerability of IBP-9414 Administered in Preterm Infants.
Status: Enrolling
Updated: 12/28/2017
UCLA Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
IBP-9414 for the Prevention of Necrotizing Enterocolitis
A Randomized, Double Blind, Parallel-group, Dose Escalation Placebo-controlled Multicenter Study to Investigate the Safety and Tolerability of IBP-9414 Administered in Preterm Infants.
Status: Enrolling
Updated:  12/28/2017
Duke Univ Med Ctr
mi
from
Durham, NC
IBP-9414 for the Prevention of Necrotizing Enterocolitis
A Randomized, Double Blind, Parallel-group, Dose Escalation Placebo-controlled Multicenter Study to Investigate the Safety and Tolerability of IBP-9414 Administered in Preterm Infants.
Status: Enrolling
Updated: 12/28/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
IBP-9414 for the Prevention of Necrotizing Enterocolitis
A Randomized, Double Blind, Parallel-group, Dose Escalation Placebo-controlled Multicenter Study to Investigate the Safety and Tolerability of IBP-9414 Administered in Preterm Infants.
Status: Enrolling
Updated:  12/28/2017
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
IBP-9414 for the Prevention of Necrotizing Enterocolitis
A Randomized, Double Blind, Parallel-group, Dose Escalation Placebo-controlled Multicenter Study to Investigate the Safety and Tolerability of IBP-9414 Administered in Preterm Infants.
Status: Enrolling
Updated: 12/28/2017
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
IBP-9414 for the Prevention of Necrotizing Enterocolitis
A Randomized, Double Blind, Parallel-group, Dose Escalation Placebo-controlled Multicenter Study to Investigate the Safety and Tolerability of IBP-9414 Administered in Preterm Infants.
Status: Enrolling
Updated:  12/28/2017
Hahnemann University Hospital
mi
from
Philadelphia, PA
IBP-9414 for the Prevention of Necrotizing Enterocolitis
A Randomized, Double Blind, Parallel-group, Dose Escalation Placebo-controlled Multicenter Study to Investigate the Safety and Tolerability of IBP-9414 Administered in Preterm Infants.
Status: Enrolling
Updated: 12/28/2017
Hahnemann University Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
IBP-9414 for the Prevention of Necrotizing Enterocolitis
A Randomized, Double Blind, Parallel-group, Dose Escalation Placebo-controlled Multicenter Study to Investigate the Safety and Tolerability of IBP-9414 Administered in Preterm Infants.
Status: Enrolling
Updated:  12/28/2017
Einstein Medical Center Philadelphia
mi
from
Philadelphia, PA
IBP-9414 for the Prevention of Necrotizing Enterocolitis
A Randomized, Double Blind, Parallel-group, Dose Escalation Placebo-controlled Multicenter Study to Investigate the Safety and Tolerability of IBP-9414 Administered in Preterm Infants.
Status: Enrolling
Updated: 12/28/2017
Einstein Medical Center Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated:  1/16/2018
Community Clinical Trials
mi
from
Orange, CA
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated: 1/16/2018
Community Clinical Trials
mi
from
Orange, CA
Click here to add this to my saved trials
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated:  1/16/2018
Rocky Mountain Gastroenterology
mi
from
Thornton, CO
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated: 1/16/2018
Rocky Mountain Gastroenterology
mi
from
Thornton, CO
Click here to add this to my saved trials
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated:  1/16/2018
Medical Research Center of Connecticut, LLC
mi
from
Hamden, CT
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated: 1/16/2018
Medical Research Center of Connecticut, LLC
mi
from
Hamden, CT
Click here to add this to my saved trials
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated:  1/16/2018
Nature Coast Clinical Research
mi
from
Inverness, FL
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated: 1/16/2018
Nature Coast Clinical Research
mi
from
Inverness, FL
Click here to add this to my saved trials
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated:  1/16/2018
Internal Medicine Specialists
mi
from
Orlando, FL
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated: 1/16/2018
Internal Medicine Specialists
mi
from
Orlando, FL
Click here to add this to my saved trials
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated:  1/16/2018
Shafran Gastroenterology Center
mi
from
Winter Park, FL
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated: 1/16/2018
Shafran Gastroenterology Center
mi
from
Winter Park, FL
Click here to add this to my saved trials
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated:  1/16/2018
Atlanta Gastroenterology Specialists, PC
mi
from
Suwanee, GA
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated: 1/16/2018
Atlanta Gastroenterology Specialists, PC
mi
from
Suwanee, GA
Click here to add this to my saved trials
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated:  1/16/2018
Commonwealth Clinical Studies
mi
from
Brockton, MA
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated: 1/16/2018
Commonwealth Clinical Studies
mi
from
Brockton, MA
Click here to add this to my saved trials
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated:  1/16/2018
University of Michigan
mi
from
Ann Arbor, MI
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated: 1/16/2018
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated:  1/16/2018
Minnesota Gastroenterology, P.A.
mi
from
Plymouth, MN
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated: 1/16/2018
Minnesota Gastroenterology, P.A.
mi
from
Plymouth, MN
Click here to add this to my saved trials
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated:  1/16/2018
Center for Digestive & Liver Diseases Inc.
mi
from
Mexico, MO
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated: 1/16/2018
Center for Digestive & Liver Diseases Inc.
mi
from
Mexico, MO
Click here to add this to my saved trials
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated:  1/16/2018
University of Nevada School of Medicine
mi
from
Las Vegas, NV
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated: 1/16/2018
University of Nevada School of Medicine
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated:  1/16/2018
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated: 1/16/2018
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated:  1/16/2018
Albany Medical College
mi
from
Albany, NY
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated: 1/16/2018
Albany Medical College
mi
from
Albany, NY
Click here to add this to my saved trials
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated:  1/16/2018
Weill Cornell Medical College of Cornell University
mi
from
New York, NY
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated: 1/16/2018
Weill Cornell Medical College of Cornell University
mi
from
New York, NY
Click here to add this to my saved trials
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated:  1/16/2018
Premier Medical Group of the Hudson Valley
mi
from
Poughkeepsie, NY
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated: 1/16/2018
Premier Medical Group of the Hudson Valley
mi
from
Poughkeepsie, NY
Click here to add this to my saved trials
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated:  1/16/2018
UNC Memorial Hospital
mi
from
Chapel Hill, NC
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated: 1/16/2018
UNC Memorial Hospital
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated:  1/16/2018
Gastro One
mi
from
Germantown, TN
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated: 1/16/2018
Gastro One
mi
from
Germantown, TN
Click here to add this to my saved trials
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated:  1/16/2018
Baylor College of Medicine - Baylor Medical Center
mi
from
Houston, TX
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated: 1/16/2018
Baylor College of Medicine - Baylor Medical Center
mi
from
Houston, TX
Click here to add this to my saved trials
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated:  1/16/2018
Mcguire Dvamc
mi
from
Richmond, VA
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated: 1/16/2018
Mcguire Dvamc
mi
from
Richmond, VA
Click here to add this to my saved trials
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated:  1/16/2018
Univeristy of Washington
mi
from
Seattle, WA
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated: 1/16/2018
Univeristy of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated:  1/16/2018
Allegiance Research Specialists
mi
from
Wauwatosa, WI
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated: 1/16/2018
Allegiance Research Specialists
mi
from
Wauwatosa, WI
Click here to add this to my saved trials
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated:  1/16/2018
Mayo Clinic Arizona (Scottsdale)
mi
from
Scottsdale, AZ
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated: 1/16/2018
Mayo Clinic Arizona (Scottsdale)
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated:  1/16/2018
The Oregon Clinic-West Hills Gastroenterology Associates, P.C.
mi
from
Portland, OR
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated: 1/16/2018
The Oregon Clinic-West Hills Gastroenterology Associates, P.C.
mi
from
Portland, OR
Click here to add this to my saved trials
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated:  1/16/2018
UCSD Altman Clinical and Translational Research Institute
mi
from
La Jolla, CA
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated: 1/16/2018
UCSD Altman Clinical and Translational Research Institute
mi
from
La Jolla, CA
Click here to add this to my saved trials
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated:  1/16/2018
Bassan and Bloom M.D.s
mi
from
Miramar, FL
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated: 1/16/2018
Bassan and Bloom M.D.s
mi
from
Miramar, FL
Click here to add this to my saved trials
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated:  1/16/2018
University of Kentucky Medical Center
mi
from
Lexington, KY
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated: 1/16/2018
University of Kentucky Medical Center
mi
from
Lexington, KY
Click here to add this to my saved trials
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated:  1/16/2018
Vanderbilt University Medical Center
mi
from
Nashville, TN
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated: 1/16/2018
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated:  1/16/2018
Washington University School of Medicine
mi
from
Saint Louis, MO
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Status: Enrolling
Updated: 1/16/2018
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Balsalazide Disodium 750 mg Capsules Under Fasting Conditions
A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Balsalazide Disodium 750 mg Capsules Under Fasting Conditions
Status: Enrolling
Updated:  1/19/2018
Novum Pharmaceutical Research Services
mi
from
Houston, TX
A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Balsalazide Disodium 750 mg Capsules Under Fasting Conditions
A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Balsalazide Disodium 750 mg Capsules Under Fasting Conditions
Status: Enrolling
Updated: 1/19/2018
Novum Pharmaceutical Research Services
mi
from
Houston, TX
Click here to add this to my saved trials
Bioequivalency Study of Balsalazide Capsules Under Fasting Conditions
A Single Dose, Two-Period, Two-Treatment, Randomized Crossover Bioequivalency Study of 750 mg Balsalazide Capsules Under Fasting Conditions
Status: Enrolling
Updated:  1/19/2018
Novum Pharmaceuticals Research Services
mi
from
Houston, TX
Bioequivalency Study of Balsalazide Capsules Under Fasting Conditions
A Single Dose, Two-Period, Two-Treatment, Randomized Crossover Bioequivalency Study of 750 mg Balsalazide Capsules Under Fasting Conditions
Status: Enrolling
Updated: 1/19/2018
Novum Pharmaceuticals Research Services
mi
from
Houston, TX
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Birmingham Gastroenterology Associates P.C.
mi
from
Birmingham, AL
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Birmingham Gastroenterology Associates P.C.
mi
from
Birmingham, AL
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Premeire Pharmaceutical Research
mi
from
Tempe, AZ
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Premeire Pharmaceutical Research
mi
from
Tempe, AZ
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Medical Services of NWA
mi
from
Fayetteville, AR
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Medical Services of NWA
mi
from
Fayetteville, AR
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
AGMG Clinical Research Institute
mi
from
Anaheim, CA
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
AGMG Clinical Research Institute
mi
from
Anaheim, CA
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Discovery Clinical Research
mi
from
Encinitas, CA
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Discovery Clinical Research
mi
from
Encinitas, CA
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Digestive & Liver Disease Specialists
mi
from
Garden Grove, CA
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Digestive & Liver Disease Specialists
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
West Gastroenterology Medical Group
mi
from
Los Angeles, CA
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
West Gastroenterology Medical Group
mi
from
Los Angeles, CA
Click here to add this to my saved trials